ArticleMolecular therapy oncolytics2020

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model.

Jamal Alzubi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.